Ebola

Ebola, dem sanso know as Ebola virus disease (EVD) den Ebola hemorrhagic fever (EHF), be a viral hemorrhagic fever insyd humans den oda primates, wey ebolaviruses cause. Symptoms typically dey start anywer between two days den three weeks after infection. De first symptoms usually be fever, sore throat, muscle pain, den headaches. Dese usually be followed by vomiting, diarrhoea, rash den decreased liver den kidney function, at wich point sam people begin to bleed both internally den externally. Ebola get a mortality rate of 25–90% wey dey depend on treatment, den averages a mortality rate of approximately 50%. Death often be secof shock from fluid loss, den typically dey occur between 6 den 16 days after de first symptoms appear. Early treatment of symptoms dey increase de survival rate considerably dem compare to late start.Ebola in Uganda:  Na dem approve an Ebola vaccine by de US FDA insyd December 2019.

De virus dey spread thru direct contact plus body fluids, such as blood from infected humans anaa oda animals, anaa from contact plus items wey recently dem be contaminated plus infected body fluids. Der be no documented cases, either insyd nature anaa under laboratory conditions, of spread thru de air between humans anaa oda primates. After recovering from Ebola, semen anaa breast milk fi continue to carry de virus for anywer between several weeks to several months. Dem dey believe fruit bats to be de natural host of de virus; dem be able to spread de virus widout dem be affected by am. De symptoms of Ebola fi resemble those of several oda diseases, wey dey include malaria, cholera, typhoid fever, meningitis den oda viral hemorrhagic fevers. Diagnosis be confirmed by testing blood samples for de presence of viral RNA, viral antibodies anaa de virus einself.

Control of outbreaks dey require coordinated medical services den community engagement, wey dey include rapid detection, contact tracing of those wey be exposed, quick access to laboratory services, care for those infected, den proper disposal of de dead thru cremation anaa burial. Prevention measures dey involve wearing proper protective clothing den washing hands wen in close proximity to patients den while handling potentially infected bushmeat, as well as thoroughly cooking bushmeat. Two treatments (atoltivimab/maftivimab/odesivimab den ansuvimab) be associated plus improved outcomes. Supportive efforts sanso improve outcomes. Dese dey include oral rehydration therapy (drinking slightly sweetened den salty water) anaa giving intravenous fluids, den treating symptoms. Insyd October 2020, na dem approve atoltivimab/maftivimab/odesivimab (Inmazeb) for medical use insyd de United States to treat de disease caused by Zaire ebolavirus.

 References 

 External links 

 WHO fact sheet on Ebola
 Ebola (Ebola Virus Disease) – Centers for Disease Control and Prevention, Viral Special Pathogens Branch.
 Videos: Ebola outbreak response – World Health Organization.

 Ebola: What You Need to Know – Scientific American articles related to Ebola; note these are general reading articles, they are not scientific peer-reviewed research articles.


Category:Animal viral diseases
Category:Articles wey dey contain video clips
Category:Bat virome
Category:Biological agents
Category:Health insyd Africa
Category:Hemorrhagic fevers
Category:Sexually transmitted diseases den infections
Category:Tropical diseases
Category:Virus-related cutaneous conditions
Category:West African Ebola virus epidemic
Category:Zoonotic viral diseases
Category:Vaccine-preventable diseases
Category:Translated from MDWiki